Article Text

Download PDFPDF

The voting system
  1. Roberto Frontini1,2
  1. 1European Association of Hospital Pharmacists, Brussels, Belgium
  2. 2Universitätsklinikum Leipzig, Leipzig, Germany
  1. Correspondence to Dr Roberto Frontini, European Association of Hospital Pharmacists, Rue Abbé Cuypers, 3, Brussels B-1040, Belgium; president{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The voting system for the summit was developed with two major aims: first to keep a balance between the groups and second to differentiate the levels of agreement in order to identify implementation priorities.

As the European Association of Hospital Pharmacists (EAHP) has 34 members, each with a vote, first it was necessary to weight the votes of patient groups and other healthcare professionals (HCP; ie, physicians and nurses) to achieve a 50:25:25 balance. Each association attending the summit had one delegate. Thus pharmacists had a total 34 votes, while patients and HCP had 17 each. The aim was to avoid one group overruling another through numerical superiority. As 31 EAHP members ultimately attended the summit, this proportion was changed to 31:15.5:15.5. The weighting factor was calculated with the formula:Embedded Image

As 12 patient groups attended the summit, their vote was weighted byEmbedded Image

And as seven HCP associations attended the summit, their vote was weighted byEmbedded Image

In this way it was impossible for pharmacists to overrule the decisions of patients and HCP just because they were in a majority.

Voting on a statement was only valid if at least 90% of the delegates expressed their opinion. Thus, out of the 31+12+7=50 delegates, at least 45 had to vote. A quorum was achieved for all statements and for 34 statements (77%) all delegates voted.

The delegates voting had four choices: strongly agreed, agreed, disagreed and strongly disagreed. Each possibility was weighted by points ranging from +2 (strongly agreed) to −1 (strongly disagreed).

Strong agreement was defined as ≥85% of the maximum number of points, that is, 85% of the points achievable if all voting delegates had strongly agreed:Embedded Image

Agreement was defined as ≥85% of the number of points achievable if all delegates had agreed:Embedded Image

For both these levels of agreement, the maximum number of points was reduced for the 10 statements where some delegates abstained.

During the Delphi process, it was intended to review any statements with between 34 and 58 points, but in practice this system was not used as changes were also made by agreement in order to optimise the wording. At the summit, statements with less than 53 points would have failed but this did not happen due to the intensive Delphi process.

Table 1 summarises the levels of agreement and figure 1 the whole voting system.

Table 1

Overview of levels of agreement by points and actual number of delegates at the summit

Figure 1

Overview of the voting system. The numbers of votes and points are in relation to the total number of member associations of the European Association of Hospital Pharmacists (EAHP). HCP, healthcare professionals; p, points.

Votes were anonymous, but the three groups (pharmacists, patients and HCP) were identified by the different frequency channels of the voting devices they used. This was necessary in order to calculate the results.

All detailed results and parameters are available online.1 The voting system was explained to all participants by written information before the summit and was described again at the beginning of the summit to make sure that all delegates were aware of the system and understood it. No objections were made.

Summit Participants List

EAHP Members


Gunar Stemer, Austrian Association of Hospital Pharmacists


Claudine Ligneel, Vlaamse vereniging van ziekenhuisapothekers (VZA)

Sophie Lorent, Association francophone des pharmaciens hospitaliers de Belgique (AFPHB)


Velina Grigorova, Bulgarian Association of Hospital Pharmacists


Kota Miroslav, Croatian Pharmaceutical Society–Hospital Pharmacy Section

Czech Republic

Marek Lzicar, Czech Association of Hospital Pharmacists


Kirsten Lykke Vorbeck, Pharmadanmark – Hospital


Marika Saar, Estonian Society of Hospital Pharmacists


Carita Linden-Lahti, The Finnish Pharmacist's Association


Niccolo Curatolo, European Fellowship for Pharmacists

Former Yugoslav Republic of Macedonia (F.Y.R.O.M)

Biljana Lazarova, Pharmaceutical Chamber of Macedonia


Steffen Amann, ADKA – The German Society of Hosptial Pharmacists


Despina Makridaki, Panhellenic Association of Hospital Pharmacists


András Süle, Hungarian Society of Hospital Pharmacists


Thorunn Kristin Gudmundsdottir, Pharmaceutical Society of Iceland, Hospital Pharmacy Section


Nuala Doyle, Hospital Pharmacists Association of Ireland (HPAI)


Simona Creazzola, Società Italiana di Farmacia Ospedaliera (SIFO)


Inese Sviestina, The Pharmacist's Society of Latvia


Sylvain Rodenbach, Association des Pharmaciens Hospitaliers Luxembourgeois

Julie Schelinsky, Association des Pharmaciens Hospitaliers Luxembourgeois


Valerie Vella, Malta Association of Hospital Pharmacy


Frank Jorgensen, Norwegian Association of Hospital Pharmacists


Maria Helena Farinha Martins, The Portuguese Association of Hospital Pharmacists (APFH)


The Polish Pharmaceutical Chamber awarded a proxy vote to the Czech Association of Hospital Pharmacists.


Paul Andreianu, The National Association of Hospital Pharmacists from Romania (ANFSR)


Nenad Miljkovic, Pharmaceutical Association of Serbia


Adriana Durcanska, Slovak Pharmaceutical Chamber


Franci Tratar, Slovenian pharmaceutical society – Section of hospital pharmacists


Sari Frigård, Swedish Association of Pharmaceutical Sciences Section for Hospital Pharmacy

Magnus Munge, Swedish Association of Pharmaceutical Sciences Section for Hospital Pharmacy


Priska Vonbach, Swiss Association of Public Health Administration and Hospital Pharmacists (GSASA)

The Netherlands

Arnold Vulto, Dutch Association of Hospital Pharmacists (NVZA)


The Turkish Hospital Pharmacists Section awarded a proxy vote to the Panhellenic Association of Hospital Pharmacists


David Miller, The Guild of Healthcare Pharmacists (GHP)

Graeme Richardson, The Guild of Healthcare Pharmacists

Patient Representatives

Laura Savini of the European Haemophilia Consortium attended the first day of the Summit and awarded a proxy vote to Rare Diseases Europe (Eurordis) for the second day.

Laurent Louette of the European Heart Network attended the first day of the Summit and awarded a proxy vote to the European Public Health Alliance (EPHA) for the second day.

European Patients' Forum awarded a proxy vote to Rare Diseases Europe (Eurordis)

Yves Brand of the European Multiple Sclerosis Platform attended the first day of the Summit and award a proxy vote to European Aids Treatment Group for the second day.

Luc Matthysen, Rare Diseases Europe (Eurordis)

Giorgio Barbareschi and Mariana Vicente, The European Aids Treatment Group

Mihaela Militaru, The European Cancer Patient Coalition

Cathalijne Van Doorne, The European Federation of Neurological Associations

Hildrun Sundseth, The European Institute of Women's Health

Heather Clarke, The European Parkinson's Disease Association

Sascha Marschang, The European Public Health Alliance

Katie Gallagher, The International Diabetes Federation (Europe)

Healthcare Professional Representatives

Antony Bertrand, European Association of Senior Physicians

Marianne de Visser, European Federation of Neurological Societies

Dominique Bron, European Haematology Association

The European Nurses in Diabetes (FEND) awarded a proxy vote to European Specialist Nurses Organisations.

The European Oncology Nursing Society awarded a proxy vote to European Specialist Nurses Organisations.

Ber Oomen, European Specialist Nursing Organisations

Patricia Messmer, The Council of International Neonatal Nurses

Summit Facilitators

Neal Maskrey

Lee Vermeulen

Andy Hutchinson

Emma Lowry

Jonathan Underhill

Cheryl McKay

Helen Stubbs

Louise Bates

EAHP Board Members

Roberto Frontini, EAHP President

Tajda Miharija-Gala, EAHP Vice President

Tony West, Director of Finances

Joan Peppard, Director of Professional Development (EAHP President-Elect)

Cees Neef, Director of Education, Science and Research

Aida Batista, Director of Professional Development

Juraj Sykora, Director of Professional Development

Francesca Venturini, Director of Professional Development Apologies were received from Petr Horák, Director of Professional Development.


David Witmer, American Society of Health Systems Pharmacists

Frederik Ulrichs, Baxter

Gery Demeusy, Carefusion

Silvia Ravera, Council of Europe–European Directorate for the Quality of Medicines and HealthCare (EDQM)

Ulrike Mayer, Employed Community Pharmacists in Europe

Serge Caillier, Employed Community Pharmacists in Europe

Joao Jose Joaquim, European Association of Pharmacy Technicians

Carlos Miguel Figueira, European Association of Pharmacy Technicians

Phil Wiffen, European Journal of Hospital Pharmacy

Björn Ellger, European Patient Safety Foundation

Tiia Metiäinen, European Pharmaceutical Students Association

Jorge Batista, European Pharmaceutical Students Association

Olga Kozhaeva, European Society of Paediatric Oncology

Marianne Ivey, International Pharmaceutical Federation (FIP)

Rob Moss, International Pharmaceutical Federation (FIP)

Jacqueline Surugue, International Pharmaceutical Federation (FIP)

Gysbrecht Goossens, Pfizer

Claus Hemmingsen, Pfizer

Yves Prevoo, Pfizer

Jamie Wilkinson, Pharmaceutical Group of the European Union (PGEU)

Jan Smits, Pharmaceutical Group of the European Union (PGEU)

Constance Colin, The Standing Committee of European Doctors

Roberta Savli and Jelena Malinina, The European Federation of Allergy and Airways Diseases Patients' Associations

EAHP Secretariat

Jennie De Greef, Chief Operating Officer

Richard Price, Policy & Advocacy Officer

David Preece, Research Assistant

Taviana Caminiti, Events Coordinator

Martina De Gregorio, Events Assistant

Sandra Teixeira, Executive Assistant–Business Development

Elizabeth Van Staeyen, Sponsorship Coordinator



  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.